Area of research
Immunology · Oncology
Research interest
Research interests include TLR9, Breast cancer, Cancer research, Cancer, Biology, and Medicine.
Discovery and evaluation of nNav1.5 sodium channel blockers with potent cell invasion inhibitory activity in breast cancer cells
Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans
Tumor infiltrating CD8<sup>+</sup>T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma
Toll-Like Receptor 9 in Breast Cancer
Toll-Like Receptors in Esophageal Cancer
Hypoxia regulates Toll-like receptor-9 expression and invasive function in human brain cancer cells in vitro
Toll‐like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue
Toll-Like Receptor-9 Expression Does not Predict for Breast Cancer Specific Outcome in African-American Triple-Negative Breast Cancer Patients
Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer
DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells
Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer
Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer
Short <scp>DNA</scp> sequences and bacterial <scp>DNA</scp> induce esophageal, gastric, and colorectal cancer cell invasion